[go: up one dir, main page]

DK0858341T3 - Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatin - Google Patents

Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatin

Info

Publication number
DK0858341T3
DK0858341T3 DK96930553T DK96930553T DK0858341T3 DK 0858341 T3 DK0858341 T3 DK 0858341T3 DK 96930553 T DK96930553 T DK 96930553T DK 96930553 T DK96930553 T DK 96930553T DK 0858341 T3 DK0858341 T3 DK 0858341T3
Authority
DK
Denmark
Prior art keywords
cisplatin
advanced cancer
combination therapy
cancer including
including temozolomide
Prior art date
Application number
DK96930553T
Other languages
Danish (da)
English (en)
Inventor
Margaret H Dugan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK0858341T3 publication Critical patent/DK0858341T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DK96930553T 1995-08-28 1996-08-26 Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatin DK0858341T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US287795P 1995-08-28 1995-08-28
US62479596A 1996-03-27 1996-03-27
PCT/US1996/013479 WO1997007804A1 (en) 1995-08-28 1996-08-26 Combination therapy for advanced cancer comprising temozolomide and cisplatin

Publications (1)

Publication Number Publication Date
DK0858341T3 true DK0858341T3 (da) 2001-11-19

Family

ID=26670993

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96930553T DK0858341T3 (da) 1995-08-28 1996-08-26 Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatin

Country Status (11)

Country Link
EP (1) EP0858341B1 (de)
JP (1) JPH10511108A (de)
AT (1) ATE207359T1 (de)
AU (1) AU6955396A (de)
CA (1) CA2229141A1 (de)
DE (1) DE69616367T2 (de)
DK (1) DK0858341T3 (de)
ES (1) ES2162092T3 (de)
GR (1) GR3037047T3 (de)
PT (1) PT858341E (de)
WO (1) WO1997007804A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1251850E (pt) * 2000-01-26 2006-10-31 Schering Corp Utilizacao de uma preparacao de combinacao na terapia do cancro
PT2338487E (pt) * 2006-01-17 2013-12-16 Abbvie Bahamas Ltd Terapia de combinação com inibidores de parp
SG10201500028RA (en) 2006-04-05 2015-02-27 Opko Health Inc Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
PE20120545A1 (es) 2006-04-05 2012-05-21 Opko Health Inc Composicion farmaceutica que comprende la forma i cristalina de la sal clorhidrato monohidrato de (5s,8s)-8-[{(1r)-1-(3,5-bis-(trifluorometil)fenil)-etoxi}-metil]-8-fenil-1,7-diazaspiro[4,5]decan-2-ona
WO2010081825A2 (en) * 2009-01-13 2010-07-22 Proteosys Ag Pirenzepine as an agent in cancer treatment
US20230056846A1 (en) * 2020-01-13 2023-02-23 Memorial Sloan Kettering Cancer Center Methods and compositions for cancer immunotherapy

Also Published As

Publication number Publication date
CA2229141A1 (en) 1997-03-06
GR3037047T3 (en) 2002-01-31
MX9801585A (es) 1998-05-31
ES2162092T3 (es) 2001-12-16
JPH10511108A (ja) 1998-10-27
AU6955396A (en) 1997-03-19
DE69616367T2 (de) 2002-06-27
PT858341E (pt) 2002-03-28
EP0858341B1 (de) 2001-10-24
DE69616367D1 (de) 2001-11-29
EP0858341A1 (de) 1998-08-19
ATE207359T1 (de) 2001-11-15
WO1997007804A1 (en) 1997-03-06

Similar Documents

Publication Publication Date Title
DE69532961D1 (de) Verwendung von porphyrine in der behandlung von multiple sklerose
FI971290A0 (fi) Multippeliskleroosin (MS) ja muiden myeliinikadosta aiheutuvien sairauksien hoito
DE69617469D1 (de) Behandlung von multipler sklerose
GEP20002146B (en) Therapeutic Peptide Derivatives
KR950700749A (ko) 2'-할로메틸리덴 유도체와 S-기 또는 M-기 특이성 항종양제를 사용하는 결합치료에 의한 암치료 방법(Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a S-phase or M phase specific antineoplastic agent)
CY1108629T1 (el) Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου
DE69426334D1 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
ATE327800T1 (de) Behandlung von darm- oder blasenentzündungen
DK0858341T3 (da) Kombinationsbehandling af fremskreden cancer omfattende temozolomid og cisplatin
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
DK0986393T3 (da) Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer
IL121440A0 (en) The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
CY1105564T1 (el) Θεραπεια συνδυασμου για καρκινο
DK0859630T3 (da) Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer
DE69218200D1 (de) Behandlung von leberkrebs
SU1823193A1 (ru) Способ лечения рака гортани
NO984196L (no) FremgangsmÕte for behandling av stoffmisbruk
UA10928C2 (uk) Спосіб профілактики гіперхолестериhемії
MX9603833A (es) Tratamiento mejorado del cancer con temozolomida.
WO2000033823A3 (en) Methods of using temozolomide in the treatment of cancers
UA10221A (uk) Спосіб лікування рецидивного бронхіту у дітей
DE60316927D1 (de) Verwendung von devazepide als schmerzmittel
UA28928A (uk) Спосіб лікування гнійно-запальних захворювань м'яких тканин
RU97114158A (ru) Способ лечения злокачественных опухолей